AKCEA THERAPEUTICS, INC.
DelistedCIK 1662524fmd_16PKAQTYXQZDSASYXGJMN4EJMQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2020, 19 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 43 | 65 | 489 |
| Research and development | 51 | 68 | 127 | 130 | 293 |
| Selling, general and administrative | – | 15 | 37 | 154 | 182 |
| Total operating expenses | 61 | 84 | 164 | 296 | – |
| Operating income | (61) | (84) | (120) | (231) | 38 |
| Other non-operating income (expense) | – | 0 | 0 | (0) | (1) |
| Income before taxes | (61) | (83) | (120) | (225) | 43 |
| Income tax expense | 0 | 0 | 1 | 0 | 2 |
| Net income from continuing operations | (61) | (83) | (122) | (226) | 41 |
| Net income | (61) | (83) | (122) | (226) | 41 |
| Net income to common shareholders | (61) | (83) | (142) | (234) | 27 |